Old Web
English
Sign In
Acemap
>
authorDetail
>
Sylvia Vetrhus
Sylvia Vetrhus
Pemetrexed
Cisplatin
Internal medicine
Oncology
Medicine
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data
2021
Journal for ImmunoTherapy of Cancer
Magnus Jaderberg
Luis Paz-Ares
Susana Cedrés
Charles Ricordel
Nicolas Isambert
Santiago Ponce-Aix
Victor Levitsky
Lukasz Kuryk
Anne-Sophie W. Møller
Sylvia Vetrhus
Show All
Source
Cite
Save
Citations (0)
361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes
2020
Journal for ImmunoTherapy of Cancer
Magnus Jaderberg
Susana Cedrés
Luis Paz-Ares
Xavier Serres
Charles Ricordel
Nicolas Isambert
Santiago Ponce-Aix
Victor Levitsky
Lukasz Kuryk
Anne-Sophie W. Møller
Sylvia Vetrhus
Show All
Source
Cite
Save
Citations (1)
1